Thyroid C-cell Tumors: In rodent studies, semaglutide is shown to trigger thyroid C-cell tumors. It is unfamiliar no matter whether this risk relates to human beings, but semaglutide is contraindicated in sufferers with a private or family members heritage of medullary thyroid carcinoma (MTC) or people with A number of Endocrine Neoplasia syndrome